Sort
82,697 grants matching “vaccine development”
Development and Production of HIV Vaccines and Adjuvants
$10,557,332Jason Gall · National Institute Of Allergy And Infectious Diseases · ZIB · FY2023 · AI
REGIONAL PRIMATE RESEARCH CENTER
$10,531,578University Of Washington · P51 · FY2001 · RR
Northeast Biodefense Center
$10,511,238W. Ian Lipkin · Columbia University Health Sciences · U54 · FY2010 · AI
Production of a Broadly Neutralizing HIV Antibodies
$10,505,669Jason Gall · National Institute Of Allergy And Infectious Diseases · ZIB · FY2020 · AI
Development/production of universal influenza vaccines
$10,496,412Frank Arnold · National Institute Of Allergy And Infectious Diseases · ZIB · FY2019 · AI
Bioinformatics Approach to Influenza A/H1N1 Vaccine Immune Profiling
$10,482,503Gregory A. Poland · Mayo Clinic Rochester · U01 · FY2012 · AI
Design and Development of a Pan-betacoronavirus Vaccine
$10,478,045Barton F Haynes · Duke University · P01 · FY2023 · AI
SUPPORT FOR NATIONAL PRIMATE RESEARCH CENTER
$10,452,394Oregon Health And Science University · P51 · FY2005 · RR
Cervical Cancer Moonshot
$10,446,162Mark Schiffman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2023 · CA
New England Regional Center of Excellence for Biodefens*
$10,436,968Dennis L. Kasper · Harvard Medical School · U54 · FY2006 · AI
Cancer Center Support Grant (Comprehensive)
$10,429,029Lawrence Corey · Fred Hutchinson Cancer Research Center · P30 · FY2011 · CA
Development of a SARS Coronavirus Vaccine
$10,427,728Novartis Vaccines And Diagnostics, Inc. · UC1 · FY2004 · AI
New England Regional Center of Excellence for Biodefens*
$10,425,237Dennis L. Kasper · Harvard Medical School · U54 · FY2008 · AI
SDMC - IMPAACT Leadership Group
$10,345,835David Eric Shapiro · Harvard School Of Public Health · UM1 · FY2018 · AI
Adol. Medicine Trials Network for HIV/AIDS Interventions
$10,327,650James J Korelitz · Westat, Inc. · U01 · FY2008 · HD
RAPID ACCELERATION OF DIAGNOSTICS (RADX) TECH PROGRAM - PROJECT #6658
$10,295,000David Yoo · Genbody Inc. · N02 · FY2021 · HL
New England Regional Center of Excellence for Biodefense
$10,253,895Dennis L. Kasper · Harvard Medical School · U54 · FY2007 · AI
SERCEB Southeast Regional Centers of Excellence for Bio*
$10,247,734Duke University · U54 · FY2005 · AI
SDMC: HIV Vaccine Trials Network
$10,240,739Peter B. Gilbert · Fred Hutchinson Cancer Research Center · UM1 · FY2014 · AI
SERCEB Southeast Regional Centers of Excellence for Bio*
$10,189,682Philip Frederick Sparling · Univ Of North Carolina Chapel Hill · U54 · FY2008 · AI
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations
$10,188,376Ted Ross · University Of Georgia · N01 · FY2022 · AI
Cancer and Leukemia Group B
$10,184,300University Of Chicago · U10 · FY2003 · CA
Development/Production-Alternative Serotype HIV Recombinant Adenoviral Vaccine
$10,159,913Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2016 · AI
Collaborative Influenza Vaccine Innovation Centers (CIVICs) Component A: Vaccine Center
$10,146,052Tony Moody · Duke University · N01 · FY2022 · AI
NIAID- VRC- Research, Development, and Production to Support Clinical Trials for HIV Vaccines.
$10,143,220David Lindsay · Leidos Biomedical Research, Inc. · N01 · FY2022 · AI